Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples

Emerging infectious diseases(2020)10.3201/eid2612.203309Source: DataRank Database

Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples is a research paper published in Emerging infectious diseases (2020). On theSindex it has a DataRank of 0. It has been cited 96 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access96 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.79)OA: goldTopics (77)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Stephen Taylor ORCID,Siân E. Jossi ORCID,Marisol Pérez-Toledo ORCID,Sian Faustini ORCID,Edith Marcial‐Juárez ORCID

Live enrichment

PubMed:32969788 PMC:PMC7706975 OpenAlex:https://openalex.org/W3088125306

Gates Foundation

Grant: INV-008813

Medical Research Council

Grant: MC_PC_17183

NIAID NIH HHS

Grant: UM1 AI144462

Wellcome Trust

Grant: unidentified

unidentified

Wellcome Trust

FWCI

1.79

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://wwwnc.cdc.gov/eid/article/26/12/pdfs/20-3309.pdf

publisherhttps://wwwnc.cdc.gov/eid/article/26/12/pdfs/20-3309.pdf

publisherhttps://wwwnc.cdc.gov/eid/article/26/12/20-3309_article

journalhttps://doi.org/10.3201/eid2612.203309

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32969788

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingBiosimilars and Bioanalytical Methods0301 basic medicine0303 health sciences03 medical and health sciencesAntibodies, ViralCOVID-19COVID-19 Serological TestingCase-Control StudiesDried Blood Spot TestingHumansPredictive Value of TestsSARS-CoV-2Spike Glycoprotein, Coronavirus

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Serological TestingAntibodies, ViralHumansPredictive Value of TestsCase-Control StudiesDried Blood Spot TestingSpike Glycoprotein, Coronavirus

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyAntibodyDried blood spotCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSars virusBiologyMedicineImmunologyInfectious disease (medical specialty)PathologyOutbreakGeneticsDiseaseVirusesDBSZoonosesRespiratory InfectionsCovid-19Sars-cov-2Severe Acute Respiratory Syndrome Coronavirus 2Coronavirus DiseaseBlood samplingInfectious and parasitic diseasesRC109-216FOS: Health sciencesAntibodies, ViralDiagnostic Methods for COVID-19 DetectionInternal medicineImmunology and MicrobiologyRDispatchLife SciencesDried Blood SpotsInfectious DiseasesSerologyEnvironmental healthSpike Glycoprotein, CoronavirusPopulation610Coronavirus Disease 2019 ResearchImmunogenicity of Biosimilar Therapeutics in Drug DevelopmentCOVID-19 Serological TestingPredictive Value of TestsHealth SciencesHumansPandemicFOS: Clinical medicineCoronavirusCase-Control StudiesFOS: Biological sciencesDried Blood Spot Testing

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

10.6084/m9.figshare.19211330.v1figshare

Additional file 1 of Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

10.6084/m9.figshare.19211330figshare